News and reflections from the world of AI

Epredia and Aiforia announce partnership for global distribution of AI-powered pathology software

Portsmouth, NH, USA, June 21, 2021 – Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions for image analysis in pathology, have announced today that they have entered into a commercial distribution agreement for Aiforia’s comprehensive portfolio of workflow enhancing solutions which enable ...

Aiforia announces CE-IVD mark for AI-supported breast cancer diagnostics

First-of-its kind diagnostic tool Aiforia today announced the CE-IVD Mark for the Aiforia® Clinical AI Model for Breast Cancer; Ki67, a widely used key biomarker in breast cancer diagnostics across pathology labs around the world. The AI Model is able to calculate Ki67 positive and negative cells in invasive areas of human breast tissue in whole slide images (WSI) as well as in specific areas — ...

Neuroscientist Joan Compte discusses benefits of AI in Parkinson’s disease image analysis

What is PD? Parkinson’s disease (PD) is a neurological disorder characterized by the degeneration of dopamine releasing regions in the brain. The loss of dopamine leads to a chronic and progressive decrease in movement, coordination, and cognition. While there is no cure, an early diagnosis promotes treatment efficacy and prolongs a higher quality of life.

Aiforia Raises €12.6M in Series B Funding to Enhance Precision Diagnostics and Preclinical Analysis in Pathology

Helsinki – June 3, 2021 - Aiforia, a software company providing AI-based solutions for clinical and preclinical image analysis in pathology, announced today the closing of the first €12.6M tranche of their Series B round. The funding round has the potential to reach €25.2M if investors exercise the optional second tranche. The funding round is led by Epredia's UK entity, a subsidiary of PHC ...

Automating the detection of malaria parasites in blood smear

Introduction Malaria is a life-threatening disease caused by Plasmodium parasites and transmitted through the bites of infected female Anopheles mosquitoes. There are five parasite species that cause malaria in humans of which P. falciparum and P. vivax pose the greatest threat, often progressing to severe illness, multi-organ failure, or death.

Interview with veterinary pathologist on AI-assisted screening of bone marrow cellularity changes

Bone marrow cellularity is the volume ratio of hematopoiesis (the body’s manufacturing of blood cells) and fat, and decreases with age. Many compounds can alter the cellularity of bone marrow making it a vital tissue for analysis by pathologists in pharmacologic safety studies. Quantitative data is vital for statistical evaluation in risk and toxicity assessments.